Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized phase II trial to evaluate the efficacy of adjuvant consolidative
radiotherapy in colorectal cancer liver metastasis (CRLM) patients after chemotherapy
combined with surgical resection or radiofrequency ablation of liver lesions.